Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2011, Article ID 128318, 37 pages
http://dx.doi.org/10.4061/2011/128318
Research Article

Schizophrenia: A Pathogenetic Autoimmune Disease Caused by Viruses and Pathogens and Dependent on Genes

Polygenic Pathways, 20 Upper Maze Hill, St Leonards-on-Sea, East Sussex, TN38 OLG, UK

Received 30 November 2010; Accepted 25 February 2011

Academic Editor: Man W. Tan

Copyright © 2011 C. J. Carter. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Crow, “How and why genetic linkage has not solved the problem of psychosis: review and hypothesis,” American Journal of Psychiatry, vol. 164, no. 1, pp. 13–21, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. J. Owen, N. Craddock, and M. C. O'Donovan, “Schizophrenia: genes at last?” Trends in Genetics, vol. 21, no. 9, pp. 518–525, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. J. Carter, “Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability,” Schizophrenia Research, vol. 86, no. 1–3, pp. 1–14, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. J. Carter, “eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?” Schizophrenia Bulletin, vol. 33, no. 6, pp. 1343–1353, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. K. Khler, S. Djurovic, L. M. Rimol et al., “Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 Is associated with disease risk and cortical surface area,” Biological Psychiatry, vol. 69, no. 1, pp. 90–96, 2011. View at Publisher · View at Google Scholar · View at PubMed
  6. P. Jia, L. Wang, H. Y. Meltzer, and Z. Zhao, “Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data,” Schizophrenia Research, vol. 122, no. 1–3, pp. 38–42, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. C. O'Dushlaine, E. Kenny, E. Heron et al., “Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility,” Molecular Psychiatry, vol. 16, no. 3, pp. 286–292, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. K. Nicodemus, A. J. Law, E. Radulescu et al., “Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls,” Archives of General Psychiatry, vol. 67, no. 10, pp. 991–1001, 2010. View at Google Scholar
  9. M. E. Talkowski, G. Kirov, M. Bamne et al., “A network of dopaminergic gene variations implicated as risk factors for schizophrenia,” Human Molecular Genetics, vol. 17, no. 5, pp. 747–758, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. K. Nicodemus, J. H. Callicott, R. G. Higier et al., “Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging,” Human Genetics, vol. 127, no. 4, pp. 441–452, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. S. Brown, P. Cohen, S. Greenwald, and E. Susser, “Nonaffective psychosis after prenatal exposure to rubella,” American Journal of Psychiatry, vol. 157, no. 3, pp. 438–443, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Adams, R. E. Kendell, E. H. Hare, and P. Munk-Jorgensen, “Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data,” British Journal of Psychiatry, vol. 163, pp. 522–534, 1993. View at Google Scholar · View at Scopus
  13. A. S. Brown, M. D. Begg, S. Gravenstein et al., “Serologic evidence of prenatal influenza in the etiology of schizophrenia,” Archives of General Psychiatry, vol. 61, no. 8, pp. 774–780, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. E. F. Torrey, R. Rawlings, and I. N. Waldman, “Schizophrenic births and viral diseases in two states,” Schizophrenia Research, vol. 1, no. 1, pp. 73–77, 1988. View at Publisher · View at Google Scholar · View at Scopus
  15. P. B. Mortensen, C. B. Pedersen, D. M. Hougaard et al., “A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring,” Schizophrenia Research, no. 1–3, pp. 257–263, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. G. Stober, E. Franzek, and H. Beckmann, “Pregnancy infections in mothers of chronic schizophrenic patients. The significance of differential nosology [Schwangerschaftsinfektionen bei Muttern von chronisch Schizophrenen. Die Bedeutung einer differenzierten Nosologie],” Nervenarzt, vol. 65, no. 3, pp. 175–182, 1994. View at Google Scholar
  17. J. Suvisaari, J. Haukka, A. Tanskanen, T. Hovi, and J. Lönnqvist, “Association between prenatal exposure to poliovirus infection and adult schizophrenia,” American Journal of Psychiatry, vol. 156, no. 7, pp. 1100–1102, 1999. View at Google Scholar · View at Scopus
  18. P. Rantakallio, P. Jones, J. Moring, and L. von Wendt, “Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up,” International Journal of Epidemiology, vol. 26, no. 4, pp. 837–843, 1997. View at Publisher · View at Google Scholar
  19. R. H. Yolken and E. F. Torrey, “Are some cases of psychosis caused by microbial agents? A review of the evidence,” Molecular Psychiatry, vol. 13, no. 5, pp. 470–479, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Fritzsche, “Seasonal correlation of sporadic schizophrenia to Ixodes ticks and Lyme borreliosis,” International Journal of Health Geographics, vol. 1, article 2, 2002. View at Publisher · View at Google Scholar
  21. H. Karlsson, S. Bachmann, J. Schröder, J. McArthur, E. F. Torrey, and R. H. Yolken, “Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4634–4639, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. J. Carter, “Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii,” Schizophrenia Bulletin, vol. 35, no. 6, pp. 1163–1182, 2009. View at Google Scholar · View at Scopus
  23. J. Sun, P. Jia, A. H. Fanous et al., “Schizophrenia gene networks and pathways and their applications for novel candidate gene selection,” PLoS One, vol. 5, no. 6, Article ID e11351, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. N. Müller, “The role of the cytokine network in the CNS and psychic disorders,” Nervenarzt, vol. 68, no. 1, pp. 11–20, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Rothermundt, V. Arolt, and T. A. Bayer, “Review of immunological and immunopathological findings in schizophrenia,” Brain, Behavior, and Immunity, vol. 15, no. 4, pp. 319–339, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. Theodoropoulou, G. Spanakos, C. N. Baxevanis et al., “Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients,” Schizophrenia Research, vol. 47, no. 1, pp. 13–25, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. K. F. Tanaka, F. Shintani, Y. Fujii, G. Yagi, and M. Asai, “Serum interleukin-18 levels are elevated in schizophrenia,” Psychiatry Research, vol. 96, no. 1, pp. 75–80, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. C. O'Donnell, S. V. Catts, P. B. Ward et al., “Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder,” Psychiatry Research, vol. 65, no. 3, pp. 171–178, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Ganguli, B. S. Rabin, R. H. Kelly, M. Lyte, and U. Ragu, “Clinical and laboratory evidence of autoimmunity in acute schizophrenia,” Annals of the New York Academy of Sciences, vol. 496, pp. 676–685, 1987. View at Google Scholar · View at Scopus
  30. M. Makinodan, K. Tatsumi, T. Manabe et al., “Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring,” Journal of Neuroscience Research, vol. 86, no. 10, pp. 2190–2200, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. F. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Larsen, O. Lund, and M. Nielsen, “Improved method for predicting linear B-cell epitopes,” Immunome Research, vol. 2, p. 2, 2006. View at Google Scholar
  33. S. Goto, H. Bono, H. Ogata et al., “Organizing and computing metabolic pathway data in terms of binary relations,” Pacific Symposium on Biocomputing, pp. 175–186, 1997. View at Google Scholar · View at Scopus
  34. M. Pirooznia, V. Nagarajan, and Y. Deng, “GeneVenn—a web application for comparing gene lists using Venn diagrams,” Bioinformation, vol. 1, pp. 420–422, 2007. View at Google Scholar
  35. D. Kanduc, “Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes,” Biologics, vol. 4, pp. 245–261, 2010. View at Google Scholar
  36. S. Himelhoch, J. F. McCarthy, D. Ganoczy et al., “Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis,” Psychosomatics, vol. 50, no. 1, pp. 30–37, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. J. G. Baillargeon, D. P. Paar, H. Wu et al., “Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting,” AIDS Care, vol. 20, no. 1, pp. 124–129, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. P. Carney, L. Jones, and R. F. Woolson, “Medical comorbidity in women and men with schizophrenia: a population-based controlled study,” Journal of General Internal Medicine, vol. 21, no. 11, pp. 1133–1137, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. F. Cournos, K. McKinnon, and G. Sullivan, “Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus,” Journal of Clinical Psychiatry, vol. 66, no. 6, pp. 27–33, 2005. View at Google Scholar · View at Scopus
  40. M. S. van der Knaap, J. C. Pronk, and G. C. Scheper, “Vanishing white matter disease,” The Lancet Neurology, vol. 5, no. 5, pp. 413–423, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. N. Uranova, D. Orlovskaya, O. Vikhreva et al., “Electron microscopy of oligodendroglia in severe mental illness,” Brain Research Bulletin, vol. 55, no. 5, pp. 597–610, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Vostrikov, D. Orlovskaya, and N. Uranova, “Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia,” World Journal of Biological Psychiatry, vol. 9, no. 1, pp. 34–42, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. V. M. Vostrikov, “Decreased numerical density of pericapillary oligodendrocytes in the cortex in schizophrenia,” Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 107, no. 12, pp. 58–65, 2007. View at Google Scholar · View at Scopus
  44. Y. Hakak, J. R. Walker, C. Li et al., “Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4746–4751, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. D. R. Friedlander, P. Milev, L. Karthikeyan, R. K. Margolis, R. U. Margolis, and M. Grumet, “The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth,” Journal of Cell Biology, vol. 125, no. 3, pp. 669–680, 1994. View at Google Scholar · View at Scopus
  46. A. Sandvig, M. Berry, L. B. Barrett, A. Butt, and A. Logan, “Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration,” Glia, vol. 46, no. 3, pp. 225–251, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. Z. J. Chen, Y. Ughrin, and J. M. Levine, “Inhibition of axon growth by oligodendrocyte precursor cells,” Molecular and Cellular Neuroscience, vol. 20, no. 1, pp. 125–139, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. H. P. Li, A. Oohira, M. Ogawa, K. Kawamura, and H. Kawano, “Aberrant trajectory of thalamocortical axons associated with abnormal localization of neurocan immunoreactivity in the cerebral neocortex of reeler mutant mice,” European Journal of Neuroscience, vol. 22, no. 11, pp. 2689–2696, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. K. Verhoeven, P. de Jonghe, T. van de Putte et al., “Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10,” American Journal of Human Genetics, vol. 73, no. 4, pp. 926–932, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. D. Ben-Shachar and R. Karry, “Neuroanatomical pattern of mithochondrial complex I pathology varies between schizoprenia, bipolar disorder and major depression,” PLoS One, vol. 3, no. 11, Article ID e3676, 2008. View at Publisher · View at Google Scholar · View at PubMed
  51. E. Y. Yuen and Z. Yan, “Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex,” Journal of Neuroscience, vol. 29, no. 2, pp. 550–562, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. K. Fukunaga and Y. Takeuchi, “Novel intracellular signal transduction of dopamine D2 receptor in schizophrenia,” Tanpakushitsu Kakusan Koso, vol. 51, no. 11, pp. 1602–1608, 2006. View at Google Scholar · View at Scopus
  53. T. Miyakawa, L. M. Leiter, D. J. Gerber et al., “Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8987–8992, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. J. P. B. Viola and A. Rao, “Role of the cyclosporin-sensitive transcription factor NFAT1 in the allergic response,” Memorias do Instituto Oswaldo Cruz, vol. 92, supplement 2, pp. 147–155, 1997. View at Google Scholar · View at Scopus
  55. A. Andrieux, P. A. Salin, M. Vernet et al., “The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders,” Genes and Development, vol. 16, no. 18, pp. 2350–2364, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. A. Andrieux, P. A. Salin, and D. Job, “A role for the cytoskeleton in mental diseases? [Un rôle pour les microtubules dans les pathologies psychiatriques?],” Pathologie Biologie, vol. 52, no. 2, pp. 89–92, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. A. Arcangeli, B. Rosati, A. Cherubini et al., “HERG- and IRK-like inward rectifier currents are sequentially expressed during neuronal development of neural crest cells and their derivatives,” European Journal of Neuroscience, vol. 9, no. 12, pp. 2596–2604, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. G. A. M. Smith, H. W. Tsui, E. W. Newell et al., “Functional up-regulation of HERG K channels in neoplastic hematopoietic cells,” Journal of Biological Chemistry, vol. 277, no. 21, pp. 18528–18534, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. J. Gommeaux, C. Grégoire, P. Nguessan et al., “Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes,” European Journal of Immunology, vol. 39, no. 4, pp. 956–964, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. A. Buonanno, O. B. Kwon, L. Yan et al., “Neuregulins and neuronal plasticity: possible relevance in schizophrenia,” Novartis Foundation Symposium, vol. 289, pp. 165–177, 2008. View at Google Scholar · View at Scopus
  61. P. Seeman, “Glutamate and dopamine components in schizophrenia,” Journal of Psychiatry and Neuroscience, vol. 34, no. 2, pp. 143–149, 2009. View at Google Scholar · View at Scopus
  62. N. A. Uranova, V. M. Vostrikov, D. D. Orlovskaya, and V. I. Rachmanova, “Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium,” Schizophrenia Research, vol. 67, no. 2-3, pp. 269–275, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. C. Winter, T. J. Reutiman, T. D. Folsom et al., “Dopamine and serotonin levels following prenatal viral infection in mouse-Implications for psychiatric disorders such as schizophrenia and autism,” European Neuropsychopharmacology, vol. 18, no. 10, pp. 712–716, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. J. K. Millar, J. C. Wilson-Annan, S. Anderson et al., “Disruption of two novel genes by a translocation co-segregating with schizophrenia,” Human Molecular Genetics, vol. 9, no. 9, pp. 1415–1423, 2000. View at Google Scholar · View at Scopus
  65. L. M. Camargo, Q. Wang, and N. J. Brandon, “What can we learn from the disrupted in schizophrenia 1 interactome: lessons for target identification and disease biology?” Novartis Foundation Symposium, vol. 289, pp. 208–216, 2008. View at Google Scholar · View at Scopus
  66. W. Hennah and D. Porteous, “The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes,” PLoS One, vol. 4, no. 3, Article ID e4906, 2009. View at Publisher · View at Google Scholar · View at PubMed
  67. S. Rossner, U. Ueberham, R. Schlichs, J. R. Perez-Polo, and V. Bigl, “Neurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells,” Journal of Neural Transmission, Supplement, no. 54, pp. 279–285, 1998. View at Google Scholar · View at Scopus
  68. A. Katzourakis and R. J. Gifford, “Endogenous viral elements in animal genomes,” PLoS Genetics, vol. 6, no. 11, Article ID e1001191, 2010. View at Publisher · View at Google Scholar · View at PubMed
  69. M. B. Geuking, J. Weber, M. Dewannieux et al., “Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration,” Science, vol. 323, no. 5912, pp. 393–396, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. K. Tanaka-Taya, J. Sashihara, H. Kurahashi et al., “Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA,” Journal of Medical Virology, vol. 73, no. 3, pp. 465–473, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. K. Khodosevich, Y. Lebedev, and E. Sverdlov, “Endogenous retroviruses and human evolution,” Comparative and Functional Genomics, vol. 3, no. 6, pp. 494–498, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. A. S. Brown, “Prenatal infection as a risk factor for schizophrenia,” Schizophrenia Bulletin, vol. 32, no. 2, pp. 200–202, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. K. Ozawa, K. Hashimoto, T. Kishimoto, E. Shimizu, H. Ishikura, and M. Iyo, “Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia,” Biological Psychiatry, vol. 59, no. 6, pp. 546–554, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. H. G. Kinnell, “Parental age in schizophrenia,” British Journal of Psychiatry, vol. 142, p. 204, 1983. View at Google Scholar · View at Scopus
  75. J. Lopez-Castroman, D. D. Gómez, J. J. C. Belloso et al., “Differences in maternal and paternal age between Schizophrenia and other psychiatric disorders,” Schizophrenia Research, vol. 116, no. 2-3, pp. 184–190, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. A. S. Brown, P. Cohen, S. Greenwald, and E. Susser, “Nonaffective psychosis after prenatal exposure to rubella,” American Journal of Psychiatry, vol. 157, no. 3, pp. 438–443, 2000. View at Publisher · View at Google Scholar
  77. C. Dalman, P. Allebeck, D. Gunnell et al., “Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects,” American Journal of Psychiatry, vol. 165, no. 1, pp. 59–65, 2008. View at Publisher · View at Google Scholar · View at PubMed
  78. K. M. Prasad, M. N. Bamne, B. H. Shirts et al., “Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia,” Schizophrenia Research, vol. 118, no. 1–3, pp. 232–239, 2010. View at Publisher · View at Google Scholar · View at PubMed
  79. D. W. Niebuhr, A. M. Millikan, R. Yolken, Y. Li, and N. S. Weber, “Results from a hypothesis generating case-control study: herpes family viruses and schizophrenia among military personnel,” Schizophrenia Bulletin, vol. 34, no. 6, pp. 1182–1188, 2008. View at Publisher · View at Google Scholar · View at PubMed
  80. A. L. Abrahao, R. Focaccia, and W. F. Gattaz, “Childhood meningitis increases the risk for adult schizophrenia,” World Journal of Biological Psychiatry, vol. 6, no. 2, pp. 44–48, 2005. View at Publisher · View at Google Scholar · View at PubMed
  81. H. Terayama, Y. Nishino, M. Kishi, K. Ikuta, M. Itoh, and K. Iwahashi, “Detection of anti-Borna Disease Virus (BDV) antibodies from patients with schizophrenia and mood disorders in Japan,” Psychiatry Research, vol. 120, no. 2, pp. 201–206, 2003. View at Publisher · View at Google Scholar
  82. S. L. Buka, T. D. Cannon, E. F. Torrey, and R. H. Yolken, “Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring,” Biological Psychiatry, vol. 63, no. 8, pp. 809–815, 2008. View at Publisher · View at Google Scholar · View at PubMed
  83. E. G. Severance, F. B. Dickerson, R. P. Viscidi et al., “Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms,” Schizophrenia Bulletin, vol. 37, no. 1, pp. 101–107, 2011. View at Publisher · View at Google Scholar · View at PubMed
  84. L. M. Ellman, R. H. Yolken, S. L. Buka, E. F. Torrey, and T. D. Cannon, “Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection,” Biological Psychiatry, vol. 65, no. 12, pp. 1040–1047, 2009. View at Publisher · View at Google Scholar · View at PubMed
  85. Y. Yao, J. Schröder, C. Nellåker et al., “Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia,” Genes, Brain and Behavior, vol. 7, no. 1, pp. 103–112, 2008. View at Publisher · View at Google Scholar · View at PubMed
  86. A. S. Brown, C. A. Schaefer, C. P. Quesenberry, L. Liu, V. P. Babulas, and E. S. Susser, “Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring,” American Journal of Psychiatry, vol. 162, no. 4, pp. 767–773, 2005. View at Publisher · View at Google Scholar · View at PubMed
  87. F. Dickerson, C. Stallings, A. Origoni, C. Copp, S. Khushalani, and R. Yolken, “Antibodies to measles in individuals with recent onset psychosis,” Schizophrenia Research, vol. 119, no. 1–3, pp. 89–94, 2010. View at Publisher · View at Google Scholar · View at PubMed
  88. G. P. Amminger, P. D. McGorry, G. E. Berger et al., “Antibodies to infectious agents in individuals at ultra-high risk for psychosis,” Biological Psychiatry, vol. 61, no. 10, pp. 1215–1217, 2007. View at Publisher · View at Google Scholar · View at PubMed
  89. M. J. Chandley, M. N. Miller, C. N. Kwasigroch, T. D. Wilson, and B. E. Miller, “Increased antibodies for the α7 subunit of the nicotinic receptor in schizophrenia,” Schizophrenia Research, vol. 109, no. 1–3, pp. 98–101, 2009. View at Publisher · View at Google Scholar · View at PubMed
  90. T. Borda, R. Gomez, M. I. Berría, and L. Sterin-Borda, “Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera,” Glia, vol. 45, no. 2, pp. 144–154, 2004. View at Publisher · View at Google Scholar · View at PubMed
  91. Y. Suzuki, T. Kurita, K. Sakurai, Y. Takeda, and T. Koyama, “Case report of anti-NMDA receptor encephalitis suspected of schizophrenia,” Seishin Shinkeigaku Zasshi, vol. 111, no. 12, pp. 1479–1484, 2009. View at Google Scholar
  92. I. V. Shcherbakova, T. M. Siryachenko, N. A. Mazaeva, V. G. Kaleda, S. A. Krasnolobova, and T. P. Klyushnik, “Leukocyte elastase and autoantibodies to nerve growth factor in the acute phase of schizophrenia and their relationship to symptomatology,” World Journal of Biological Psychiatry, vol. 5, no. 3, pp. 143–148, 2004. View at Publisher · View at Google Scholar
  93. S. Tanaka, H. Matsunaga, M. Kimura et al., “Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders,” Journal of Neuroimmunology, vol. 141, no. 1-2, pp. 155–164, 2003. View at Publisher · View at Google Scholar
  94. X. F. Wang, D. Wang, W. Zhu, K. K. Delrahim, D. Dolnak, and M. H. Rapaport, “Studies characterizing 60 kDa autoantibodies in subjects with schizophrenia,” Biological Psychiatry, vol. 53, no. 5, pp. 361–375, 2003. View at Publisher · View at Google Scholar
  95. J. J. Kim, S. J. Lee, K. Y. Toh, C. U. Lee, C. Lee, and I. H. Paik, “Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia,” Schizophrenia Research, vol. 52, no. 1-2, pp. 127–135, 2001. View at Publisher · View at Google Scholar
  96. A. B. Poletaev, S. G. Morozov, B. B. Gnedenko, V. M. Zlunikin, and D. A. Korzhenevskey, “Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders,” Autoimmunity, vol. 32, no. 1, pp. 33–38, 2000. View at Google Scholar
  97. A. Chatr-Aryamontri, A. Ceol, D. Peluso et al., “VirusMINT: a viral protein interaction database,” Nucleic Acids Research, vol. 37, no. 1, pp. D669–D673, 2009. View at Publisher · View at Google Scholar · View at PubMed
  98. C. J. Carter, “Herpes simplex: host viral protein interactions,” WikiGenes, 2010.
  99. S. Lan, H. Wang, H. Jiang et al., “Direct interaction between α-actinin and hepatitis C virus NS5B,” FEBS Letters, vol. 554, no. 3, pp. 289–294, 2003. View at Publisher · View at Google Scholar
  100. E. Forgacs, S. K. Gupta, J. A. Kerry, and O. J. Semmes, “The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) tax and represses HTLV-1 long terminal repeat-mediated transcription,” Journal of Virology, vol. 79, no. 11, pp. 6932–6939, 2005. View at Publisher · View at Google Scholar · View at PubMed
  101. S. V. Indran, M. E. Ballestas, and W. J. Britt, “Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells,” Journal of Virology, vol. 84, no. 7, pp. 3162–3177, 2010. View at Publisher · View at Google Scholar · View at PubMed
  102. Y. P. Huang, J. Cheng, S. L. Zhang et al., “Screening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid system,” World Journal of Gastroenterology, vol. 11, no. 36, pp. 5659–5665, 2005. View at Google Scholar
  103. K. Radtke, D. Kieneke, A. Wolfstein et al., “Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures,” PLoS Pathogens, vol. 6, no. 7, Article ID e1000991, 2010. View at Publisher · View at Google Scholar · View at PubMed
  104. K. H. Bremner, J. Scherer, J. Yi, M. Vershinin, S. P. Gross, and R. B. Vallee, “Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit,” Cell Host and Microbe, vol. 6, no. 6, pp. 523–535, 2010. View at Publisher · View at Google Scholar · View at PubMed
  105. H. Si, S. C. Verma, M. A. Lampson, Q. Cai, and E. S. Robertson, “Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation,” Journal of Virology, vol. 82, no. 13, pp. 6734–6746, 2008. View at Publisher · View at Google Scholar · View at PubMed
  106. H. N. Ramanathan, D. H. Chung, S. J. Plane et al., “Dynein-dependent transport of the Hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment,” Journal of Virology, vol. 81, no. 16, pp. 8634–8647, 2007. View at Publisher · View at Google Scholar · View at PubMed
  107. B. Schramm, C. A. M. de Haan, J. Young et al., “Vaccinia-virus-induced cellular contractility facilitates the subcellular localization of the viral replication sites,” Traffic, vol. 7, no. 10, pp. 1352–1367, 2006. View at Publisher · View at Google Scholar · View at PubMed
  108. I. J. Dorweiler, S. J. Ruone, H. Wang, R. W. Burry, and L. M. Mansky, “Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release,” Journal of Virology, vol. 80, no. 7, pp. 3634–3643, 2006. View at Publisher · View at Google Scholar · View at PubMed
  109. K. Kobayashi, T. Sueyoshi, K. Inoue, R. Moore, and M. Negishi, “Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells,” Molecular Pharmacology, vol. 64, no. 5, pp. 1069–1075, 2003. View at Publisher · View at Google Scholar · View at PubMed
  110. K. H. Bremner, J. Scherer, J. Yi, M. Vershinin, S. P. Gross, and R. B. Vallee, “Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit,” Cell Host and Microbe, vol. 6, no. 6, pp. 523–535, 2010. View at Publisher · View at Google Scholar · View at PubMed
  111. E. Johannsen, M. Luftig, M. R. Chase et al., “Proteins of purified Epstein-Barr virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 46, pp. 16286–16291, 2004. View at Publisher · View at Google Scholar · View at PubMed
  112. A. J. Collier, J. Gallego, R. Klinck et al., “A conserved RNA structure within the HCV IRES eIF3-binding site,” Nature Structural Biology, vol. 9, no. 5, pp. 375–380, 2002. View at Publisher · View at Google Scholar · View at PubMed
  113. H. Sawa, T. Suzuki, Y. Orba, Y. Sunden, and K. Nagashima, “Recent research on the JC virus,” Brain and Nerve, vol. 59, no. 2, pp. 101–108, 2007. View at Google Scholar
  114. R. M. Vos, J. Altreuter, E. A. White, and P. M. Howley, “The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability,” Journal of Virology, vol. 83, no. 17, pp. 8885–8892, 2009. View at Publisher · View at Google Scholar · View at PubMed
  115. R. König, Y. Zhou, D. Elleder et al., “Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication,” Cell, vol. 135, no. 1, pp. 49–60, 2008. View at Publisher · View at Google Scholar · View at PubMed
  116. A. A. Kondratova, N. Neznanov, R. V. Kondratov, and A. V. Gudkov, “Poliovirus protein 3A binds and inactivates LIS1, causing block of membrane protein trafficking and deregulation of cell division,” Cell Cycle, vol. 4, no. 10, pp. 1403–1410, 2005. View at Google Scholar
  117. N. Epie, T. Ammosova, T. Sapir et al., “HIV-1 Tat interacts with LIS1 protein,” Retrovirology, vol. 2, 2005. View at Publisher · View at Google Scholar · View at PubMed
  118. Y. Verdier and B. Penke, “Binding sites of amyloid β-peptide in cell plasma membrane and implications for Alzheimer's disease,” Current Protein and Peptide Science, vol. 5, no. 1, pp. 19–31, 2004. View at Publisher · View at Google Scholar
  119. I. Bossis, R. B. S. Roden, R. Gambhira et al., “Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection,” Journal of Virology, vol. 79, no. 11, pp. 6723–6731, 2005. View at Publisher · View at Google Scholar · View at PubMed
  120. C. R. Brunetti, K. S. Dingwell, C. Wale, F. L. Graham, and D. C. Johnson, “Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms,” Journal of Virology, vol. 72, no. 4, pp. 3330–3339, 1998. View at Google Scholar
  121. D. T. Balu and J. T. Coyle, “Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia,” Neuroscience and Biobehavioral Reviews, vol. 35, no. 3, pp. 848–870, 2011. View at Publisher · View at Google Scholar · View at PubMed
  122. S. J. Flint, L. W. Enquist, V. R. Racaniello, and A. M. Skalka, Principles of Virology, ASM Press, Herndon, Va, USA, 2008.
  123. M. R. Rosenberg and M. G. Casarotto, “Coexistence of two adamantane binding sites in the influenza A M2 ion channel,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13866–13871, 2010. View at Publisher · View at Google Scholar · View at PubMed
  124. J. Toma, J. M. Whitcomb, C. J. Petropoulos, and W. Huang, “Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors,” AIDS, vol. 24, no. 14, pp. 2181–2186, 2010. View at Publisher · View at Google Scholar · View at PubMed
  125. C. J. Carter, “Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades,” Neurochemistry International, vol. 52, no. 6, pp. 920–934, 2008. View at Publisher · View at Google Scholar · View at PubMed
  126. K. Honjo, R. van Reekum, and N. P. L. G. Verhoeff, “Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?” Alzheimer's and Dementia, vol. 5, no. 4, pp. 348–360, 2009. View at Publisher · View at Google Scholar · View at PubMed
  127. R. F. Itzhaki, M. A. Wozniak, D. M. Appelt, and B. J. Balin, “Infiltration of the brain by pathogens causes Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 5, pp. 619–627, 2004. View at Publisher · View at Google Scholar · View at PubMed
  128. C. J. Carter, “Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner,” International Journal of Alzheimer's Disease, vol. 2010, Article ID 140539, 17 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  129. S. A. Chance, M. M. Esiri, and T. J. Crow, “Ventricular enlargement in schizophrenia: a primary change in the temporal lobe?” Schizophrenia Research, vol. 62, no. 1-2, pp. 123–131, 2003. View at Publisher · View at Google Scholar
  130. W. Hennah and D. Porteous, “The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes,” PLoS One, vol. 4, no. 3, Article ID e4906, 2009. View at Publisher · View at Google Scholar · View at PubMed
  131. L. Desbonnet, J. L. Waddington, and C. M. P. O'Tuathaigh, “Mutant models for genes associated with schizophrenia,” Biochemical Society Transactions, vol. 37, no. 1, pp. 308–312, 2009. View at Publisher · View at Google Scholar · View at PubMed
  132. H. Jaaro-Peled, “Gene models of schizophrenia: DISC1 mouse models,” Progress in Brain Research, vol. 179, pp. 75–86, 2009. View at Google Scholar
  133. N. Sakae, N. Yamasaki, K. Kitaichi et al., “Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants,” Human Molecular Genetics, vol. 17, no. 20, pp. 3191–3203, 2008. View at Publisher · View at Google Scholar · View at PubMed
  134. C. S. Barros, B. Calabrese, P. Chamero et al., “Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 11, pp. 4507–4512, 2009. View at Publisher · View at Google Scholar · View at PubMed
  135. D. Babovic, C. M. O'Tuathaigh, A. M. O'Connor et al., “Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase,” Neuroscience, vol. 155, no. 4, pp. 1021–1029, 2008. View at Publisher · View at Google Scholar · View at PubMed
  136. W. W. Eaton, M. Byrne, H. Ewald et al., “Association of schizophrenia and autoimmune diseases: linkage of Danish national registers,” American Journal of Psychiatry, vol. 163, no. 3, pp. 521–528, 2006. View at Publisher · View at Google Scholar · View at PubMed
  137. H. Rosenmann, N. Grigoriadis, D. Karussis et al., “Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein,” Archives of Neurology, vol. 63, no. 10, pp. 1459–1467, 2006. View at Publisher · View at Google Scholar · View at PubMed
  138. J. E. Black, I. M. Kodish, A. W. Grossman et al., “Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia,” American Journal of Psychiatry, vol. 161, no. 4, pp. 742–744, 2004. View at Publisher · View at Google Scholar
  139. N. S. Kolomeets and N. A. Uranova, “Synaptic contacts in schizophrenia: the study with immunocytochemical identification of dopaminergic neurons [Sinapticheskie kontakty pri shizofrenii: issledovaniie s immunotsitokhimicheskoi identifikatsiei dofaminergicheskikh neironov],” Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova, vol. 97, no. 12, pp. 39–43, 1997. View at Google Scholar
  140. P. M. Thompson, C. Vidal, J. N. Giedd et al., “Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11650–11655, 2001. View at Publisher · View at Google Scholar · View at PubMed
  141. T. A. Bayer, R. Buslei, L. Havas, and P. Falkai, “Evidence for activation of microglia in patients with psychiatric illnesses,” Neuroscience Letters, vol. 271, no. 2, pp. 126–128, 1999. View at Publisher · View at Google Scholar
  142. R. J. Holden and I. S. Pakula, “Immunological influences in attention-deficit disorder and schizophrenia: is there a link between these two conditions?” Medical Hypotheses, vol. 45, no. 6, pp. 575–587, 1995. View at Publisher · View at Google Scholar
  143. J. Söderlund, J. Schröder, C. Nordin et al., “Activation of brain interleukin-1β in schizophrenia,” Molecular Psychiatry, vol. 14, no. 12, pp. 1069–1071, 2009. View at Publisher · View at Google Scholar · View at PubMed
  144. Ł. Drzyzga, E. Obuchowicz, A. Marcinowska, and Z. S. Herman, “Cytokines in schizophrenia and the effects of antipsychotic drugs,” Brain, Behavior, and Immunity, vol. 20, no. 6, pp. 532–545, 2006. View at Publisher · View at Google Scholar · View at PubMed
  145. R. S. Smith and M. Maes, “The macrophage-T-lymphocyte theory of schizophrenia: additional evidence,” Medical Hypotheses, vol. 45, no. 2, pp. 135–141, 1995. View at Publisher · View at Google Scholar
  146. M. P. Vawter, O. Dillon-Carter, F. Issa, R. J. Wyatt, and W. J. Freed, “Transforming growth factors β1 and β2 in the cerebrospinal fluid of chronic schizophrenic patients,” Neuropsychopharmacology, vol. 16, no. 1, pp. 83–87, 1997. View at Publisher · View at Google Scholar
  147. R. Rajapakse, B. Uring-Lambert, K. L. Andarawewa et al., “1,25(OH)2D3 inhibits in vitro and in vivo intracellular growth of apicomplexan parasite Toxoplasma gondii,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3-5, pp. 811–814, 2007. View at Publisher · View at Google Scholar · View at PubMed
  148. J. J. McGrath, D. W. Eyles, C. B. Pedersen et al., “Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study,” Archives of General Psychiatry, vol. 67, no. 9, pp. 889–894, 2010. View at Publisher · View at Google Scholar · View at PubMed
  149. D. Kanduc, A. Stufano, G. Lucchese, and A. Kusalik, “Massive peptide sharing between viral and human proteomes,” Peptides, vol. 29, no. 10, pp. 1755–1766, 2008. View at Publisher · View at Google Scholar · View at PubMed
  150. D. E. Dietrich and L. Bode, “Human Borna disease virus-infection and its therapy in affective disorders,” APMIS, vol. 116, no. 124, pp. 61–65, 2008. View at Publisher · View at Google Scholar
  151. E. Fazzini, J. Fleming, and S. Fahn, “Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease,” Movement Disorders, vol. 7, no. 2, pp. 153–158, 1992. View at Google Scholar
  152. B. A. Bagert, “Epstein-Barr virus in multiple sclerosis,” Current Neurology and Neuroscience Reports, vol. 9, no. 5, pp. 405–410, 2009. View at Publisher · View at Google Scholar